Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Field Trip Health Ltd (FTRPF)

Field Trip Health Ltd (FTRPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade FTRPF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.9800 +15.38%
on 07/08/21
6.5000 -11.60%
on 07/16/21
-0.1240 (-2.11%)
since 06/28/21
3-Month
4.1100 +39.81%
on 06/02/21
6.5000 -11.60%
on 07/16/21
+0.8260 (+16.79%)
since 04/28/21

Most Recent Stories

More News
Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP

TORONTO, July 27, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic...

FTRP.TO : 1.06 (+1.92%)
FTRPF : 5.7460 (-2.32%)
FTRP-WT.TO : 0.0150 (-25.00%)
Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol "FTRP"

TORONTO, July 23, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic...

FTRP.TO : 1.06 (+1.92%)
FTRPF : 5.7460 (-2.32%)
Field Trip Health Ltd. to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit

TORONTO, July 08, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced...

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations

CLXPF : 3.0200 (-1.31%)
BABYF : 1.0600 (-3.37%)
SHIEF : 0.2000 (-0.94%)
INNPF : 0.4200 (-4.39%)
LEXX : 2.0100 (+2.03%)
DFFN : 7.93 (+3.93%)
FTRPF : 5.7460 (-2.32%)
INM : 0.8000 (+5.26%)
ARHH : 7.6500 (-4.38%)
VNRX : 2.37 (+1.72%)
AVCRF : 0.0840 (-19.15%)
SPHRY : 5.5100 (+4.06%)
Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results

TORONTO, June 24, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, reported its fiscal...

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)
Virtual Conference for Life Sciences Companies Broadcast Live June 24th, 2021

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

VNRX : 2.37 (+1.72%)
LEXX : 2.0100 (+2.03%)
DFFN : 7.93 (+3.93%)
INM : 0.8000 (+5.26%)
CLXPF : 3.0200 (-1.31%)
BABYF : 1.0600 (-3.37%)
SHIEF : 0.2000 (-0.94%)
INNPF : 0.4200 (-4.39%)
FTRPF : 5.7460 (-2.32%)
ARHH : 7.6500 (-4.38%)
AVCRF : 0.0840 (-19.15%)
SPHRY : 5.5100 (+4.06%)
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET

TORONTO, June 17, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced...

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)
“The Science Behind Using Psychedelics To Treat Mental Health Disorders And Addiction Is Compelling”

Jim Cramer discussed psychedelics on his June 15, 2021 program and said big drug companies tried, and failed, to treat major depression. Here are four psychedelic companies you need to know about that...

MNMD : 0.8000 (+3.40%)
EHVVF : 0.0077 (-23.00%)
CMPS : 7.80 (+0.39%)
LKYSF : 0.4800 (-3.63%)
FTRPF : 5.7460 (-2.32%)
Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development

Palm Beach, FL – June 15, 2021 – The modern psychedelic renaissance has empirically proven that psychedelic drugs are going to revolutionize mental health treatment. Before these incredibly promising...

OILFF : 0.0800 (+11.89%)
OILS.CN : 0.100 (+5.26%)
MNMD : 0.8000 (+3.40%)
LKYSF : 0.4800 (-3.63%)
NUMI.VN : 0.580 (+9.43%)
FTRPF : 5.7460 (-2.32%)
FTRP.CN : 5.550 (+1.46%)
CRTPF : 2.3000 (+5.50%)
CRDL.TO : 1.63 (+10.88%)
Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound

Completion of These Critical Steps Positions Company to Submit Application to Commence Phase 1 Human Trials by Year End

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 6.2907
2nd Resistance Point 6.1753
1st Resistance Point 5.9607
Last Price 5.7460
1st Support Level 5.6307
2nd Support Level 5.5153
3rd Support Level 5.3007

See More

52-Week High 7.7086
Last Price 5.7460
Fibonacci 61.8% 5.4784
Fibonacci 50% 4.7895
Fibonacci 38.2% 4.1007
52-Week Low 1.8705

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar